Skip to content

Form 4 filed by Li Zhen

Li Zhen filed this Form 4 on ADARx Pharmaceuticals, Inc. with 1 transaction row and 0 holding rows, accepted by EDGAR 2026-09-28 20:30:17 UTC.

Accession
0001729510-26-000006
Filed
2026-09-28
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

Issuer and reporting owners

Issuer: ADARx Pharmaceuticals, Inc. (CIK 1802369)

  • Li Zhen director, officer (President and CEO), 10% owner

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Employee Stock Option (right to buy) derivative2026-09-24A granted+1,024,152$01,024,152D